News Hub
The latest breaking stories
Access up-to-date news and information on a wide range of press releases including business, finance, technology, healthcare, entertainment, and more.
Discover the most important & comprehensive stories delivered directly to you daily.
- Gambling, General News
- 08/12/2025
- 05:45
All-time high poker machine losses a new all-time low for the NSW community – $2.45 billion lost in just 92 days
Media release For immediate release 8 December 2025 All-time high poker machine losses a new all-time low for the NSW community - $2.45 billion lost in just 92 days Latest figures from NSW Liquor and Gaming for Q3 2025 show poker machine losses have soared to the highest level ever in NSW history, a devastating record for the NSW community. The data, published days after the NSW Government announced long-overdue cancellation of pokies venue shutdown exemptions, proves much more needs to be done. Wesley Mission CEO, Rev Stu Cameron, says the current real reform standstill in NSW virtually guarantees record…
- Contains:
- Food Beverages, Science
- 08/12/2025
- 05:30
Coffee scraps help blueberries stay fresher, longer
Key Facts: UNSW researchers are turning what was once waste into a protective film that could help extend the expiry date of some of Australia’s favourite summer fruits.Ever splurged on a punnet (or few) of blueberries only to find them a wrinkled, grey-flecked disappointment in your fridge a few days later? You’re not alone. This little blue superfood is known for perishing quickly. But now, a team of chemical engineers from UNSW Sydney are working on slowing down that decline. They’ve developed an edible film made from coffee waste that could help preserve the freshness of delicate fruits like blueberries…
- Community, Medical Health Aged Care
- 08/12/2025
- 04:15
Global Clinical Experts Gather in Sydney to Advance Adult Duchenne Muscular Dystrophy Care
Key Facts: Life expectancy for Australians living with DMD have increased from 18 for those borne before 1970, to around 30 today. As adult care remains fragmented and inconsistent between hospitals and States, the Symposium will develop global multi-disciplinary care recommendations.MEDIA RELEASE A world-first International Symposium dedicated toimproving multi-disciplinary clinical care for adults living with Duchenne muscular dystrophy (DMD) will take place in Sydney over the next three days. Hosted by the Save Our Sons Duchenne Foundation, the invitation-only event will bring together more than 35 of the world’s leading clinicians and researchers to develop the first multidisciplinary, global best-practice…
- Contains:
- Science
- 08/12/2025
- 03:11
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
VIENNA–BUSINESS WIRE– AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized…
- Contains:
- Business Finance
- 07/12/2025
- 23:11
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed RIYADH, Saudi Arabia–BUSINESS WIRE–…
- Contains:
- Energy, Finance Investment
- 07/12/2025
- 22:30
NEW REPORT: CHINA’S RISING TIDE OF $180bn IN OVERSEAS CLEANTECH INVESTMENT SINCE 2023 DRIVES GLOBAL ENERGY TRANSITION; AUS MISSES OUT
EMBARGOED TO 10.30pm AEDT SUNDAY 7 DECEMBER 2025 CHINESE CLEANTECH INVESTMENT INTO AUSTRALIA HAS COLLAPSED, PUTTING AT RISK THE COUNTRY’S NET ZERO & INDUSTRIAL DECARBONISATION GOALS A new report released today by independent think tank Climate Energy Finance (CEF), Rising Tide: China’s Outbound Cleantech Capital Surge Drives Global Collaboration Toward Net Zero, finds that Chinese firms have committed more than US$180bn of outbound foreign direct investment (OFDI) in cleantech since the start of 2023 – up 80% since CEF’s Green Capital Tsunami report a year ago. China’s investment into cleantech manufacturing and clean energy infrastructure spanned batteries, battery materials, solar…
- Energy, Finance Investment
- 07/12/2025
- 22:30
NEW REPORT: CHINA’S RISING TIDE OF $180bn IN OVERSEAS CLEANTECH INVESTMENT SINCE 2023 DRIVES GLOBAL ENERGY TRANSITION; AUS MISSES OUT
CHINESECLEANTECH INVESTMENT INTO AUSTRALIA HAS COLLAPSED, PUTTING AT RISK THE COUNTRY’S NET ZERO & INDUSTRIAL DECARBONISATION GOALS A new report released today by independent think tank Climate Energy Finance (CEF), Rising Tide: China’s Outbound Cleantech Capital Surge Drives Global Collaboration Toward Net Zero, finds that Chinese firms have committed more than US$180bn of outbound foreign direct investment (OFDI) in cleantech since the start of 2023 – up 80% since CEF’s Green Capital Tsunami report a year ago. China’s investment into cleantech manufacturing and clean energy infrastructure spanned batteries, battery materials, solar PV, wind, EVs, hydro-electricity and green hydrogen industrial precincts…
- Government SA, Legal
- 07/12/2025
- 15:41
Vicious assaults continue in South Australian prisons
Today’s vicious assault at Yatala prison is another example of a system in crisis where low wages has led to chronicunderstaffing due to attraction and retention issues, says the Public Service Association. In the last few months there has been a number of violent assaults in SA prisons, on November 4th at Yatala Labour Prison a prisoner was king hit into unconsciousness in the engineering workshop lunch room leading to a large loss of blood. Shortly before that another brutal attack occurred inside Yatala’s Mirnu Unit 1, a facility originally designed for rehabilitation programs. Nine prisoners reportedly attacked a single…
- Medical Health Aged Care
- 07/12/2025
- 01:41
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…
Media Outreach made fast, easy, simple.
Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.